Skip to main content
Caplight Logo









Standard Model Biomedicine

Standard Model Biomedicine

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://standardmodel.bio/

Last Round

Seed

Oct 6, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Standard Model Biomedicine is a biotechnology company that develops multimodal AI foundation models to integrate biomedical data for patient outcome prediction and clinical research.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

foundation modelfrontier ai labcomputational biologydrug discoverybiotech aitarget identificationelectronic health recordEHRpatient embeddingsmultimodal aiproteomicsgenomicsbioinformaticsai drug discoverybiotech saas

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Standard Model Biomedicine Comparables

Compare Standard Model Biomedicine with similar companies based on industry and business-model similarity.

Standard Model Biomedicine comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bioptimus
83%
Enable Medicine
80%
Scienta Lab
80%

Standard Model Biomedicine Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 6, 2025

Key People

Founding team and executive leadership

Arda Pekis

Founder, CTO

Founding Team

Standard Model Biomedicine Investors

Notable investors and investment history

Standard Model Biomedicine investors
InvestorRounds
Arkitekt VenturesSeed
VirtueSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 16, 2025

    Grew 75% QoQ, from 4 to 7 employees.

  • Oct 6, 2025

    Seed round led by Virtue.

Standard Model Biomedicine Filings

Explore SEC and related filing metadata, where available.

Standard Model Biomedicine filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Standard Model Biomedicine's valuation, stock price, and market status.

Is Standard Model Biomedicine a public or private company?

Standard Model Biomedicine is a private company.

What is the current stock price of Standard Model Biomedicine?

Standard Model Biomedicine is a private company with no public stock price. No recent secondary market data is available.

How much is Standard Model Biomedicine worth (valuation)?

Valuation information for Standard Model Biomedicine is not publicly available.

Can I buy Standard Model Biomedicine stock?

Standard Model Biomedicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Standard Model Biomedicine's last funding round?

Standard Model Biomedicine's most recent funding round was Seed on September 30, 2025.

Who are the main investors in Standard Model Biomedicine?

Key investors in Standard Model Biomedicine include Virtue.

Will Standard Model Biomedicine IPO soon?

No public IPO plans have been announced for Standard Model Biomedicine.

How can I track Standard Model Biomedicine secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Standard Model Biomedicine's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range11
Year Founded2024
Last FundingOct 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?